Hyoscyamine Sulfate Tablet, Extended Release
Product Images NDC 39328-052

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hyoscyamine Sulfate (NDC 39328-052). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Patrin Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Patrin 01)

FDA Label Image

Principal Display Panel (100 Tablet Bottle Label)

Principal Display Panel (100 Tablet Bottle Label)
This is information about a medication containing 0.375 mg of hyoscyamine sulfate in extended-release tablets. It is important to follow the dosage instructions provided in the package insert. The tablets should be kept in a tight, light-resistant container with a child-resistant closure. There is a warning to keep the tablets out of reach of children. In case of accidental overdose, contact a Poison Control Center immediately. The medication should be stored at room temperature between 20-25°C (68-77°F) with excursions permitted between 15-30°C. This medicine is manufactured in the USA for Patrin Pharma.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.